|
Sucampo Presents Data for AMITIZA(R) in the Treatment of Moderate to Very …
MarketWatch (press release) 1.7%), and diarrhea (4.4% vs. 1.7%) for lubiprostone vs. placebo, respectively. AMITIZA was well-tolerated in this group of patients as well, with the most common adverse events (greater than 4%) being nausea (9.8% vs. 5.7%), diarrhea (6.7% vs. |
Sucampo Presents Data for AMITIZA(R) in the Treatment of Moderate to Very … – MarketWatch (press release)
Pfenninger: Colitis associated with antibiotic use – Midland Daily News
Pfenninger: Colitis associated with antibiotic useMidland Daily NewsThis lack of bacteria in the gut can lead to diarrhea which normally resolves rather quickly once the antibiotics are stopped. However, with the increased use of broad-spectrum antibiotics, the need to use more combination antibiotics, and the effect …and more » diarrhea – Google News
Ocera Therapeutics receives CE Mark for Zysa™ for the treatment of diarrhea … – PR Newswire (press release)
Ocera Therapeutics receives CE Mark for Zysa™ for the treatment of diarrhea …PR Newswire (press release)These include abdominal pain, diarrhea and bloating. Zysa is also marketed as Kremezin™ in Asia to treat chronic kidney disease. IBS can be extremely debilitating and is associated with economic burden in both direct medical costs and indirect social …Ocera … Continue reading
Ocera Therapeutics receives CE Mark for Zysa™ for the treatment of diarrhea … – Sacramento Bee
Ocera Therapeutics receives CE Mark for Zysa™ for the treatment of diarrhea …Sacramento BeeThese include abdominal pain, diarrhea and bloating. Zysa is also marketed as Kremezin™ in Asia to treat chronic kidney disease. IBS can be extremely debilitating and is associated with economic burden in both direct medical costs and indirect social …and more » diarrhea … Continue reading